Tag #Healthcare Economics

Showing 1 to 8 of 8 results

elpais.com

🌐 85% Global Worthiness

Jul 13, 13:11

Mexico's Booming Cosmetic Surgery Tourism

Mexico's medical tourism industry, particularly cosmetic surgery, is booming, attracting 1.4 million international patients in 2024 and generating \$8 billion in revenue, with social media playing a key role in its success.

Mexico's Booming Cosmetic Surgery Tourism

Mexico's medical tourism industry, particularly cosmetic surgery, is booming, attracting 1.4 million international patients in 2024 and generating \$8 billion in revenue, with social media playing a key role in its success.

Progress

48% Bias Score

ShareSaveArticle

Decent Work and Economic Growth

12345678

Previous 1 of 8 Next

What factors have contributed to Mexico's rise as a leading destination for international cosmetic surgery?

Mexico has become a popular destination for medical tourism, particularly cosmetic surgery, with a 35.1% share of international patients, second only to Colombia. This surge is largely due to social media marketing, where patients share their positive experiences, driving further demand. The industry generated \$8 billion in revenue in 2024, with 40% from aesthetic procedures.

forbes.com

🌐 85% Global Worthiness

May 9, 01:17

Ovarian Aging Research: Multi-Billion Dollar Implications for Women's Health

Dr. Francesca Duncan's research at the Buck Institute reveals that ovarian aging involves inflammation and fibrosis, impacting fertility and hormone production; this discovery has significant implications for women's health, workforce productivity, and healthcare costs, with potential multi-billion ...

Ovarian Aging Research: Multi-Billion Dollar Implications for Women's Health

Dr. Francesca Duncan's research at the Buck Institute reveals that ovarian aging involves inflammation and fibrosis, impacting fertility and hormone production; this discovery has significant implications for women's health, workforce productivity, and healthcare costs, with potential multi-billion ...

Progress

48% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What are the immediate implications of Dr. Duncan's discovery on women's health and the global economy?

Dr. Francesca Duncan's research reveals that ovarian aging, characterized by inflammation and fibrosis, negatively impacts follicle development, egg quality, and ovulation, significantly affecting fertility and hormone production. This discovery has substantial implications for women's health and the broader economy, impacting workforce participation and healthcare costs.

dailymail.co.uk

🌐 75% Global Worthiness

Feb 16, 07:06

UK Diabetes Epidemic: Prediabetes Programme Effectiveness Debated

A record 4.6 million people in the UK have diabetes, costing the NHS £10 billion yearly. The Diabetes Prevention Programme aims to prevent type 2 diabetes by addressing prediabetes in 6.3 million people, but its effectiveness is debated, with concerns over completion rates and differing approaches b...

UK Diabetes Epidemic: Prediabetes Programme Effectiveness Debated

A record 4.6 million people in the UK have diabetes, costing the NHS £10 billion yearly. The Diabetes Prevention Programme aims to prevent type 2 diabetes by addressing prediabetes in 6.3 million people, but its effectiveness is debated, with concerns over completion rates and differing approaches b...

Progress

16% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What is the current state of diabetes and prediabetes in the UK, and what are the immediate consequences of this health crisis?

In the UK, a record 4.6 million people have diabetes, costing the NHS £10 billion annually. The Diabetes Prevention Programme (DPP), launched in 2018, aims to mitigate this by addressing prediabetes (affecting 6.3 million), but its effectiveness is debated.

cnbc.com

🌐 75% Global Worthiness

Jan 3, 01:07

Lilly Intervenes in Lawsuit over Compounded Tirzepatide Drugs

Eli Lilly joined a lawsuit against the FDA, contesting the agency's October 2023 decision ending the shortage designation for its tirzepatide-based drugs (Zepbound and Mounjaro), impacting the legality of cheaper compounded alternatives. The FDA affirmed its decision in December, but the compounding...

Lilly Intervenes in Lawsuit over Compounded Tirzepatide Drugs

Eli Lilly joined a lawsuit against the FDA, contesting the agency's October 2023 decision ending the shortage designation for its tirzepatide-based drugs (Zepbound and Mounjaro), impacting the legality of cheaper compounded alternatives. The FDA affirmed its decision in December, but the compounding...

Progress

36% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

How does the FDA's decision on tirzepatide drug shortages affect the operations and profitability of compounding pharmacies?

This legal dispute centers on the FDA's October 2023 decision that tirzepatide drugs are not in short supply, thereby restricting compounding pharmacies' ability to produce lower-cost alternatives. Lilly's intervention underscores the conflict between the FDA's regulatory stance, the financial implications for Lilly, and the access to affordable medications for patients. The case outcome will determine the future availability and pricing of compounded tirzepatide drugs.

forbes.com

🌐 75% Global Worthiness

May 24, 19:10

Medicare Drug Pricing: Price Controls vs. Market Negotiation

The Inflation Reduction Act uses price controls rather than negotiation to set maximum drug prices, creating perverse incentives for government and private insurers that lead to under-provision of care for the sick. Future reforms should promote free-market principles.

Medicare Drug Pricing: Price Controls vs. Market Negotiation

The Inflation Reduction Act uses price controls rather than negotiation to set maximum drug prices, creating perverse incentives for government and private insurers that lead to under-provision of care for the sick. Future reforms should promote free-market principles.

Progress

56% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What perverse incentives do government and private insurers face in the current healthcare system, and how do these incentives shape the provision of care?

The IRA's price controls, while presented as negotiation, create perverse incentives for both government and private insurers. Politicians favor the healthy over the sick to maximize votes, while insurers avoid enrolling the sick due to regulations. This leads to under-provision of care to the sick and over-provision to the healthy.

forbes.com

🌐 85% Global Worthiness

Mar 17, 22:12

High Cost of GLP-1 Weight Loss Drugs Limits Cost-Effectiveness

A JAMA Health Forum study found that despite improved health outcomes, GLP-1 weight loss medications like Wegovy and Zepbound are not currently cost-effective due to high net prices, patient non-persistence, and insurer churn; price reductions of 30% for tirzepatide and 82% for semaglutide are neede...

High Cost of GLP-1 Weight Loss Drugs Limits Cost-Effectiveness

A JAMA Health Forum study found that despite improved health outcomes, GLP-1 weight loss medications like Wegovy and Zepbound are not currently cost-effective due to high net prices, patient non-persistence, and insurer churn; price reductions of 30% for tirzepatide and 82% for semaglutide are neede...

Progress

56% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What long-term strategies could improve the cost-effectiveness and equitable access of GLP-1 medications for obesity?

The lack of cost-effectiveness, coupled with high patient non-persistence (15-25% remaining on treatment after two years), poses challenges for insurers. Despite potential long-term savings from reduced comorbidities, the upfront costs and high patient churn rate make these drugs financially difficult to justify, especially considering Medicare price negotiations and high disenrollment rates may not fully solve these problems. The absence of observed medical cost offset further complicates the issue.

forbes.com

🌐 75% Global Worthiness

Feb 3, 16:11

CFPB's Medical Debt Rule: Potential for Unintended Consequences

The CFPB finalized a rule eliminating \$49 billion in medical debt from 15 million Americans' credit reports; however, this action may have unintended consequences, including degraded lending standards, higher healthcare prices, and reduced credit access for low-income individuals.

CFPB's Medical Debt Rule: Potential for Unintended Consequences

The CFPB finalized a rule eliminating \$49 billion in medical debt from 15 million Americans' credit reports; however, this action may have unintended consequences, including degraded lending standards, higher healthcare prices, and reduced credit access for low-income individuals.

Progress

56% Bias Score

ShareSaveArticle

Reduced Inequality

12345678

Previous 1 of 8 Next

How does the prevalence of medical debt in the US, considering various studies' findings, compare to the narrative presented by the Biden administration and other proponents of the CFPB rule?

The CFPB's intent is to alleviate the burden of medical debt, but data suggests this problem is less pervasive than portrayed. Studies indicate that half of those with medical debt owe under \$2,000, and many individuals manage unexpected medical costs without significant long-term financial issues. The rule's economic rationale is questionable, as it ignores the fungible nature of debt and the potential for higher healthcare costs due to reduced payment incentives.

npr.org

🌐 75% Global Worthiness

Dec 11, 07:11

Kansas City Birth Center Closure Exposes Maternal Care Crisis

The closure of New Birth Company, the only independent licensed birth center in the Kansas City area, due to inadequate insurance reimbursement, highlights the nationwide shortage of maternal care options and the struggle for birth centers to stay afloat.

Kansas City Birth Center Closure Exposes Maternal Care Crisis

The closure of New Birth Company, the only independent licensed birth center in the Kansas City area, due to inadequate insurance reimbursement, highlights the nationwide shortage of maternal care options and the struggle for birth centers to stay afloat.

Progress

36% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What is the immediate impact of the New Birth Company closure on expectant mothers in the Kansas City area?

"New Birth Company", a Kansas City-area birth center, closed in late summer 2024 due to insufficient reimbursement from Medicaid and private insurance, leaving expectant mothers like Kimberly Kleoppel scrambling to find alternative care. Kleoppel, who had planned a home-like birthing experience, was forced to deliver at home eight days before her due date. This closure eliminated the only independent, licensed birth center in the region, highlighting the increasing challenges faced by these facilities.

Showing 1 to 8 of 8 results